• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

0913693 B.C. Ltd (OP:REPCF)

0.0001 UNCHANGED
Last Price Updated: 11:11 AM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0001
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0001
Today's Range 0.0001 - 0.0001
52wk Range 0.0001 - 0.0100
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
RepliCel Provides Corporate Update
November 28, 2022
Via ACCESSWIRE
News headline image
RepliCel Announces Material Patent Milestones in Key Markets
August 04, 2022
Via ACCESSWIRE

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
-99.0%
-99.0%

More News

Read More
News headline image
DermaPrecise(TM) Injection System Shown to Produce Consistently High Cell Count and Viability for Cell Therapy Injections
August 02, 2022
Via ACCESSWIRE
News headline image
RepliCel’s Manufacturing Inspected by Japan’s PMDA
July 28, 2022
From RepliCel Life Sciences, Inc.
Via AccessWire
News headline image
RepliCel’s Manufacturing Inspected by Japan’s PMDA
July 28, 2022
Via ACCESSWIRE
News headline image
CORRECTION: Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
July 26, 2022
Via ACCESSWIRE
News headline image
CORRECTION: Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
July 26, 2022
From RepliCel Life Sciences, Inc.
Via AccessWire
News headline image
Independent Laboratory Test Results Confirm Value of DermaPrecise (TM) Injection Consistency in Clinical Simulation Testing
July 26, 2022
Via ACCESSWIRE
News headline image
Independent Laboratory Test Results Confirm Value of DermaPrecise (TM) Injection Consistency in Clinical Simulation Testing
July 26, 2022
From RepliCel Life Sciences, Inc.
Via AccessWire
News headline image
RepliCel Announces Material Patent Milestones
January 10, 2022
From RepliCel Life Sciences, Inc.
Via AccessWire
Topics Intellectual Property
News headline image
RepliCel Closed Final Tranche of Strategic Investment Commitment
December 21, 2021
From RepliCel Life Sciences, Inc.
Via AccessWire
News headline image
RepliCel Terminates License Agreement with Shiseido
December 21, 2021
From RepliCel Life Sciences, Inc.
Via AccessWire
News headline image
RepliCel Ships DermaPrecise(TM) Injector Prototypes and Consumables to Independent Laboratory for Clinical Simulation Testing
November 11, 2021
From RepliCel Life Sciences, Inc.
Via AccessWire
News headline image
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
November 09, 2021
From RepliCel Life Sciences, Inc.
Via AccessWire
News headline image
RepliCel Announces DermaPrecise Trademark for Dermal Injector Product Line
October 28, 2021
From RepliCel Life Sciences, Inc.
Via AccessWire
News headline image
RepliCel Announces Dermal Injector Update
October 27, 2021
From RepliCel Life Sciences, Inc.
Via AccessWire
News headline image
RepliCel Files Notice of Arbitration against Shiseido Company to Resolve its License Agreement Dispute Regarding its Androgenetic Alopecia Cell Therapy
October 18, 2021
From RepliCel Life Sciences, Inc.
Via AccessWire
News headline image
RepliCel Life Sciences Appoints One of Japan's Foremost Regenerative Medicine Industry Business Leaders as Strategic Advisor
October 12, 2021
From RepliCel Life Sciences, Inc.
Via AccessWire
Topics Economy
News headline image
RepliCel and University of Victoria Collaboration Leads to Bioengineering Innovations, Funding, and Patents
September 16, 2021
From RepliCel Life Sciences, Inc.
Via AccessWire
Topics Intellectual Property
News headline image
RepliCel Applies for Manufacturing Approval for Its Collagen and Tissue Regeneration Cell Therapies
July 07, 2021
From RepliCel Life Sciences, Inc.
Via AccessWire
News headline image
RepliCel Adds Independent Director
June 15, 2021
From RepliCel Life Sciences, Inc.
Via AccessWire
Topics Artificial Intelligence
News headline image
RepliCel Launches Testing of Dermal Injector Units
May 25, 2021
From RepliCel Life Sciences, Inc.
Via AccessWire
News headline image
RepliCel Launches Preparations for Second Skin Rejuvenation and Tendon Regeneration Clinical Studies
May 19, 2021
From RepliCel Life Sciences, Inc.
Via AccessWire
News headline image
RepliCel Announces Appointment of Leading Dermatologist in Japan as Clinical Advisor
May 17, 2021
From RepliCel Life Sciences, Inc.
Via AccessWire
News headline image
RepliCel Launches the Next Stage of a Research Project with the University of British Columbia to Build World-Class Hair Follicle Cell Data Map
May 11, 2021
From RepliCel Life Sciences, Inc.
Via AccessWire
Topics Intellectual Property

Frequently Asked Questions

Is 0913693 B.C. Ltd publicly traded?
Yes, 0913693 B.C. Ltd is publicly traded.
What exchange does 0913693 B.C. Ltd trade on?
0913693 B.C. Ltd trades on the OTC Traded
What is the ticker symbol for 0913693 B.C. Ltd?
The ticker symbol for 0913693 B.C. Ltd is REPCF on the OTC Traded
What is the current price of 0913693 B.C. Ltd?
The current price of 0913693 B.C. Ltd is 0.0001
When was 0913693 B.C. Ltd last traded?
The last trade of 0913693 B.C. Ltd was at 11/03/25 11:11 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap